Julia Zima is a Senior Drug Safety Physician at Sumitomo Pharma America, Inc. since October 2020, with extensive experience in pharmacovigilance and safety assessment across multiple pharmaceutical companies. Prior positions include Safety Strategy Lead at EMD Serono, Medical Director of Global Safety and Pharmacovigilance at Akebia Therapeutics, and Safety Physician in Vaccines Clinical Safety and Pharmacovigilance at GSK. Julia also served as a Senior Clinical Research Associate at Janssen and as a Clinical Research Associate at Paraxel. Educational qualifications include an ongoing MBA from Boston University, a Master's degree in Pharmacovigilance and Pharmacoepidemiology, a PhD in Clinical Pharmacology, and a Doctor of Medicine in Pediatrics, all contributing to robust expertise in drug safety and regulatory compliance.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.